BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 16116421)

  • 1. The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair.
    Bridge WL; Vandenberg CJ; Franklin RJ; Hiom K
    Nat Genet; 2005 Sep; 37(9):953-7. PubMed ID: 16116421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
    Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD
    Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FANCJ/BRIP1 recruitment and regulation of FANCD2 in DNA damage responses.
    Zhang F; Fan Q; Ren K; Auerbach AD; Andreassen PR
    Chromosoma; 2010 Dec; 119(6):637-49. PubMed ID: 20676667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional defects in the fanconi anemia pathway in pancreatic cancer cells.
    van der Heijden MS; Brody JR; Gallmeier E; Cunningham SC; Dezentje DA; Shen D; Hruban RH; Kern SE
    Am J Pathol; 2004 Aug; 165(2):651-7. PubMed ID: 15277238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the Fanconi anemia-DNA repair connection.
    Thompson LH
    Nat Genet; 2005 Sep; 37(9):921-2. PubMed ID: 16132046
    [No Abstract]   [Full Text] [Related]  

  • 6. Proteasome function is required for DNA damage response and fanconi anemia pathway activation.
    Jacquemont C; Taniguchi T
    Cancer Res; 2007 Aug; 67(15):7395-405. PubMed ID: 17671210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interplay of Fanconi anemia proteins in the DNA damage response.
    Wang X; D'Andrea AD
    DNA Repair (Amst); 2004; 3(8-9):1063-9. PubMed ID: 15279794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deubiquitination of FANCD2 is required for DNA crosslink repair.
    Oestergaard VH; Langevin F; Kuiken HJ; Pace P; Niedzwiedz W; Simpson LJ; Ohzeki M; Takata M; Sale JE; Patel KJ
    Mol Cell; 2007 Dec; 28(5):798-809. PubMed ID: 18082605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.
    Yamashita T; Nakahata T
    Int J Hematol; 2001 Jul; 74(1):33-41. PubMed ID: 11530803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for the Fanconi anemia C protein in maintaining the DNA damage-induced G2 checkpoint.
    Freie BW; Ciccone SL; Li X; Plett PA; Orschell CM; Srour EF; Hanenberg H; Schindler D; Lee SH; Clapp DW
    J Biol Chem; 2004 Dec; 279(49):50986-93. PubMed ID: 15377654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. siRNA depletion of BRCA1, but not BRCA2, causes increased genome instability in Fanconi anemia cells.
    Bruun D; Folias A; Akkari Y; Cox Y; Olson S; Moses R
    DNA Repair (Amst); 2003 Sep; 2(9):1007-13. PubMed ID: 12967657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathogenesis of fanconi anemia.
    Taniguchi T; Dandrea AD
    Int J Hematol; 2002 Feb; 75(2):123-8. PubMed ID: 11939257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between BRCA-Fanconi anemia and mismatch repair pathways prevents MSH2-dependent aberrant DNA damage responses.
    Peng M; Xie J; Ucher A; Stavnezer J; Cantor SB
    EMBO J; 2014 Aug; 33(15):1698-712. PubMed ID: 24966277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.
    Garcia-Higuera I; Taniguchi T; Ganesan S; Meyn MS; Timmers C; Hejna J; Grompe M; D'Andrea AD
    Mol Cell; 2001 Feb; 7(2):249-62. PubMed ID: 11239454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1-independent ubiquitination of FANCD2.
    Vandenberg CJ; Gergely F; Ong CY; Pace P; Mallery DL; Hiom K; Patel KJ
    Mol Cell; 2003 Jul; 12(1):247-54. PubMed ID: 12887909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway.
    Wang X; Kennedy RD; Ray K; Stuckert P; Ellenberger T; D'Andrea AD
    Mol Cell Biol; 2007 Apr; 27(8):3098-108. PubMed ID: 17296736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicase-inactivating
    Kamal L; Pierce SB; Canavati C; Rayyan AA; Jaraysa T; Lobel O; Lolas S; Norquist BM; Rabie G; Zahdeh F; Levy-Lahad E; King MC; Kanaan MN
    Cold Spring Harb Mol Case Stud; 2020 Oct; 6(5):. PubMed ID: 33028645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange.
    Wilson JB; Johnson MA; Stuckert AP; Trueman KL; May S; Bryant PE; Meyn RE; D'Andrea AD; Jones NJ
    Carcinogenesis; 2001 Dec; 22(12):1939-46. PubMed ID: 11751423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ATR- and BRCA1-mediated Fanconi anemia pathway is required for activating the G2/M checkpoint and DNA damage repair upon rereplication.
    Zhu W; Dutta A
    Mol Cell Biol; 2006 Jun; 26(12):4601-11. PubMed ID: 16738325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.